» Articles » PMID: 24476076

Posterior Reversible Encephalopathy Syndrome Due to Malignant Hypercalcemia: Physiopathological Considerations

Abstract

Context: Posterior reversible encephalopathy syndrome (PRES) is a neurological entity characterized by seizures, headache, and reversible subcortical vasogenic edema. It is associated with many etiologies, most often hypertension, chronic renal failure, and chemotherapy. Hypercalcemia is rarely associated with PRES.

Objective: The aim of this study is to describe and discuss a case of PRES that developed in a patient with malignant hypercalcemia, with emphasis on the possible pathophysiological mechanisms involved.

Patients And Methods: A 38-year-old woman presented with altered mental status. She had a 2-month history of lumbar pain of moderate intensity, weight loss, and gastrointestinal complaints, in addition to a mass in her left breast. Her corrected serum calcium was 14.5 mg/dL. She was normotensive, had no focalizing signs, and her cerebrospinal fluid was normal. Despite treatment, her neurological state did not resolve, and she developed severe headaches at day 4 of her admission. Brain magnetic resonance imaging showed a bilateral and symmetric hyperintensity in the occipital and parietal lobes on T2-weighted and fluid-attenuated inversion recovery imaging, a characteristic highly suggestive of PRES. After correction of hypercalcemia, her symptoms and imaging abnormalities resolved.

Conclusions: The development of PRES in the setting of severe hypercalcemia is extremely rare. Hypercalcemia could lead to PRES in the absence of hypertension by various mechanisms, including vasospasm, endothelial dysfunction, and an inflammatory state. A high index of suspicion is needed in this setting because hypercalcemia can lead to neurological symptomatology, and prompt diagnosis is essential for adequate treatment.

Citing Articles

Posterior reversible encephalopathy syndrome and parkinsonism as the first manifestation of primary hyperparathyroidism - a report of two cases.

Rallapalli S, Rayani M, Ninan G, Hussain M, Nair A, Bal D Endocrine. 2024; 86(3):937-942.

PMID: 39292367 DOI: 10.1007/s12020-024-04041-6.


A Novel Adult Case of Recurrent Acute Pancreatitis Caused by Hypercalcemia With Concurrent Manifestation of Posterior Reversible Encephalopathy Syndrome Revealing Undiagnosed Primary Hyperparathyroidism due to an Underlying Parathyroid Adenoma.

Ghosh R, Leon-Ruiz M, Bole K, Dubey S, Benito-Leon J Neurohospitalist. 2024; 14(2):174-177.

PMID: 38666285 PMC: 11040631. DOI: 10.1177/19418744231217768.


Posterior reversible encephalopathy syndrome secondary to malignancy-associated hypercalcemia: A case report.

Abdulla M Int J Crit Illn Inj Sci. 2024; 13(4):199-201.

PMID: 38292398 PMC: 10824200. DOI: 10.4103/ijciis.ijciis_8_23.


Malignant Hypercalcemia: A Rare Etiology of Posterior Reversible Encephalopathy Syndrome.

Odoma V, Zahedi I, Haq H, Lopez Pantoja S, Onyejide E, Rahman F Cureus. 2023; 15(6):e41229.

PMID: 37529521 PMC: 10387446. DOI: 10.7759/cureus.41229.


Cancer-related hypercalcemia and potential treatments.

Almuradova E, Cicin I Front Endocrinol (Lausanne). 2023; 14:1039490.

PMID: 37033238 PMC: 10073684. DOI: 10.3389/fendo.2023.1039490.